Suppr超能文献

采用诱导室技术和基于生物的方法治疗 AVN:适应证和临床结果。

Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results.

机构信息

Orthopaedic Reparative Surgery Department, Orthopaedic Institute Gaetano Pini, University of Milan, Italy.

Orthopaedic Reparative Surgery Department, Orthopaedic Institute Gaetano Pini, University of Milan, Italy.

出版信息

Injury. 2014 Feb;45(2):369-73. doi: 10.1016/j.injury.2013.09.014. Epub 2013 Sep 19.

Abstract

OBJECTIVE

To determine the efficacy of core decompression (CD) technique combined with recombinant morphogenetic proteins, autologous mesenchymal stem cells (MSCs) and xenograft bone substitute into the necrotic lesion of the femoral head on clinical symptoms and on the progression of osteonecrosis of the femoral head.

PATIENTS AND METHODS

A total of 38 patients (40 hips) with early stage osteonecrosis of the femoral head were studied over a 4-year period.

RESULTS

CD technique combined with recombinant morphogenetic proteins, autologous MSCs and xenograft bone substitute was associated with a significant reduction in both pain and joint symptoms and reduced the incidence of fractural stages. At 36 months, 33 patients achieved clinical and radiographic healing.

CONCLUSION

This long-term follow-up study confirmed that CD technique combined with recombinant morphogenetic proteins, autologous MSCs and xenograft bone substitute may be an effective treatment for patients with early stage osteonecrosis of the femoral head.

摘要

目的

评估核心减压(CD)技术联合重组形态发生蛋白、自体间充质干细胞(MSCs)和异种骨替代物注入股骨头坏死病灶在改善临床症状和股骨头坏死进展方面的疗效。

患者和方法

对 38 例(40 髋)早期股骨头坏死患者进行了为期 4 年的研究。

结果

CD 技术联合重组形态发生蛋白、自体 MSCs 和异种骨替代物可显著减轻疼痛和关节症状,降低骨折分期发生率。36 个月时,33 例患者获得临床和影像学愈合。

结论

这项长期随访研究证实,CD 技术联合重组形态发生蛋白、自体 MSCs 和异种骨替代物可能是治疗早期股骨头坏死的有效方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验